Last updated on September 2018

Treatment of Patients With Lesions in the Superficial Femoral or Popliteal Arteries Using Kanshas Drug Coated Balloon


Brief description of study

To assess safety and efficacy of the Kanshas DCB in the treatment of de novo lesions in the superficial femoral (SFA) and/or popliteal arteries.

Detailed Study Description

The KANSHAS 1 (K-1) trial investigates the inhibition of restenosis using the Kanshas DCB in the treatment of de novo lesions in the superficial femoral or popliteal arteries.

The proposed clinical study will be a prospective, multi-center, controlled, open, single-arm study. Up to 50 patients will be enrolled at up to 7 sites in Belgium and Germany. Follow-ups are scheduled before discharge, at 30 days, 6 months, 1, and 2 years. Each patient will have a follow-up contact via hospital visit and telephone.

Clinical Study Identifier: NCT02939924

Contact Investigators or Research Sites near you

Start Over

Koen Deloose

AZ Sint Blasius
Dendermonde, Belgium
4.39miles

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.